mci 9038 has been researched along with Recrudescence in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 10 (66.67) | 18.2507 |
2000's | 3 (20.00) | 29.6817 |
2010's | 2 (13.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arachchillage, DR; Baglin, T; Besser, M; Maclean, R; van Veen, JJ | 1 |
Bay, C; Bentz, S; Memari, S; Nowroozi, S; Sharifi, M; Valeros, G | 1 |
Katz, E; Kim, KY; McNulty, I | 1 |
Aghababian, RV; Begelman, SM; Hursting, MJ; McCollum, D | 1 |
Fujita, S; Itonaga, T; Masumoto, H; Nakai, M; Nomura, R; Shimamoto, M; Yamazaki, F | 1 |
Herrman, JP; Serruys, PW | 1 |
Garabedian, HD; Gold, HK; Hagstrom, JN; Jang, IK; Khan, A; Leinbach, RC; Newell, JB; Torres, FW; Werner, W; Yasuda, T | 1 |
Casscells, W; Willerson, JT | 1 |
Fareed, J; Lewis, BE; Rangel, Y | 1 |
Kawatani, A; Kobayashi, A; Kurosawa, Y; Miki, S; Mizoguchi, T; Murata, S; Nakajima, H; Sakurai, T; Takeuchi, T; Yoshida, A | 1 |
Hirayama, F; Kawasaki, T; Koshio, H; Matsumoto, Y; Sato, K; Taniuchi, Y | 1 |
Anderson, HV; Bazzino, O; Brown, DF; Dinsmore, R; Dutra, OP; Giugliano, RP; Jang, IK; Liprandi, AS; Losordo, D; Massey, TJ; Nicolau, JC; Norbady, R; Schwarz, RP; Viamonte, VM | 1 |
Collen, D; Fallon, JT; Gold, HK; Guerrero, JL; Holt, R; Jang, IK; Leinbach, RC; Yaoita, H; Yasuda, T | 1 |
Chesebro, JH; Fuster, V | 1 |
Bush, LR; Connolly, TM; Mellott, MJ; York, SJ | 1 |
1 review(s) available for mci 9038 and Recrudescence
Article | Year |
---|---|
Thrombin and antithrombotic therapy in interventional cardiology.
Topics: Angioplasty, Balloon, Coronary; Animals; Antithrombins; Arginine; Coronary Disease; Fibrinolytic Agents; Heparin; Hirudin Therapy; Humans; Pipecolic Acids; Platelet Membrane Glycoproteins; Recurrence; Sulfonamides; Thrombin | 1994 |
4 trial(s) available for mci 9038 and Recrudescence
Article | Year |
---|---|
Thrombocytopenia following heparin flush.
Topics: Amputation, Surgical; Anticoagulants; Arginine; Catheters, Indwelling; Cause of Death; Diagnosis, Differential; Female; Hemorrhage; Heparin; Humans; Infusions, Intravenous; Male; Middle Aged; Partial Thromboplastin Time; Patient Selection; Pipecolic Acids; Platelet Count; Prospective Studies; Recurrence; Sulfonamides; Therapeutic Irrigation; Thrombocytopenia; Thrombosis; Treatment Outcome | 2005 |
Evidence for a rebound coagulation phenomenon after cessation of a 4-hour infusion of a specific thrombin inhibitor in patients with unstable angina pectoris.
Topics: Aged; Angina, Unstable; Antithrombin III; Antithrombins; Arginine; Blood Coagulation; Drug Administration Schedule; Female; Fibrinopeptide A; Humans; Infusions, Intravenous; Male; Middle Aged; Pipecolic Acids; Recurrence; Sulfonamides; Thrombin; Treatment Outcome | 1993 |
Clinical evaluation of the efficacy of an antithrombin agent "Argatroban" combined with exercise therapy on increase of the skeletal muscle blood flow.
Topics: Aged; Aged, 80 and over; Antithrombins; Arginine; Arteriosclerosis Obliterans; Blood Vessel Prosthesis Implantation; Combined Modality Therapy; Exercise Therapy; Humans; Male; Muscle, Skeletal; Pipecolic Acids; Prostaglandins E; Recurrence; Regional Blood Flow; Skin Temperature; Sulfonamides; Vasodilator Agents | 1996 |
A multicenter, randomized study of argatroban versus heparin as adjunct to tissue plasminogen activator (TPA) in acute myocardial infarction: myocardial infarction with novastan and TPA (MINT) study.
Topics: Adult; Arginine; Chemotherapy, Adjuvant; Coronary Angiography; Drug Therapy, Combination; Female; Fibrinolytic Agents; Follow-Up Studies; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion; Pipecolic Acids; Platelet Aggregation Inhibitors; Recurrence; Single-Blind Method; Sulfonamides; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome | 1999 |
10 other study(ies) available for mci 9038 and Recrudescence
Article | Year |
---|---|
Combined factor IIa and Xa inhibitor therapy for thrombosis whilst on therapeutic anticoagulant.
Topics: Adult; Aged; Anticoagulants; Antithrombins; Arginine; Dabigatran; Factor Xa Inhibitors; Female; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Neoplasms; Pipecolic Acids; Pyrazoles; Pyridones; Recurrence; Rivaroxaban; Sulfonamides; Venous Thrombosis | 2016 |
Catheter-directed thrombolysis with argatroban and tPA for massive iliac and femoropopliteal vein thrombosis.
Topics: Arginine; Catheterization, Peripheral; Catheters; Drug Therapy, Combination; Female; Femoral Vein; Fibrinolytic Agents; Follow-Up Studies; Humans; Iliac Vein; Male; Middle Aged; Phlebography; Pipecolic Acids; Platelet Aggregation Inhibitors; Popliteal Vein; Recurrence; Severity of Illness Index; Sulfonamides; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome; Venous Thrombosis | 2013 |
Heparin-induced thrombocytopenia from venous thromboembolism treatment.
Topics: Amputation, Surgical; Anticoagulants; Arginine; Drug Administration Schedule; Female; Hemorrhage; Heparin; Humans; Male; Middle Aged; Pipecolic Acids; Platelet Count; Randomized Controlled Trials as Topic; Recurrence; Retrospective Studies; Sulfonamides; Thrombocytopenia; Thromboembolism; Treatment Outcome; Warfarin | 2005 |
A case of heparin-induced thrombocytopenia with repeated episodes of acute lower extremity arterial thromboembolism during a short time.
Topics: Anticoagulants; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Female; Heparin; Heparitin Sulfate; Humans; Leg; Middle Aged; Pipecolic Acids; Recurrence; Sulfonamides; Thrombectomy; Thrombocytopenia; Thromboembolism | 2007 |
Thrombin inhibitors in unstable angina: rebound or continuation of angina after argatroban withdrawal?
Topics: Angina, Unstable; Antithrombin III; Antithrombins; Arginine; Humans; Pipecolic Acids; Recurrence; Sulfonamides; Thrombin | 1993 |
The first report of successful carotid stent implant using argatroban anticoagulation in a patient with heparin-induced thrombocytopenia and thrombosis syndrome: a case report.
Topics: Aged; Anticoagulants; Antithrombins; Arginine; Carotid Arteries; Carotid Stenosis; Catheterization; Cerebrovascular Disorders; Femoral Artery; Follow-Up Studies; Heparin; Humans; Male; Paresis; Pipecolic Acids; Platelet Aggregation Inhibitors; Recurrence; Stents; Sulfonamides; Syndrome; Thrombocytopenia; Thrombosis | 1998 |
Effect of a synthetic factor Xa inhibitor, YM-60828, on blood vessel patency in combination with a thrombolytic agent and on blood loss from the operation site in a rat model of arterial thrombosis.
Topics: Animals; Anticoagulants; Arginine; Blood Loss, Surgical; Carotid Arteries; Carotid Artery Thrombosis; Drug Evaluation, Preclinical; Hemorrhage; Heparin; Male; Naphthalenes; Pipecolic Acids; Piperidines; Rats; Recurrence; Reperfusion; Serine Proteinase Inhibitors; Sulfonamides; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator | 1998 |
Comparative effects of aspirin, a synthetic thrombin inhibitor and a monoclonal antiplatelet glycoprotein IIb/IIIa antibody on coronary artery reperfusion, reocclusion and bleeding with recombinant tissue-type plasminogen activator in a canine preparation
Topics: Animals; Antibodies, Monoclonal; Antithrombins; Arginine; Aspirin; Coronary Circulation; Coronary Disease; Coronary Thrombosis; Dogs; Pipecolic Acids; Platelet Membrane Glycoproteins; Recurrence; Sulfonamides; Thrombolytic Therapy; Tissue Plasminogen Activator; Vascular Patency | 1990 |
Reperfusion, specific thrombin inhibition and reocclusion after thrombolysis.
Topics: Animals; Antibodies, Monoclonal; Antithrombins; Arginine; Coronary Disease; Coronary Thrombosis; Dogs; Pipecolic Acids; Platelet Membrane Glycoproteins; Recurrence; Sulfonamides; Thrombolytic Therapy; Tissue Plasminogen Activator | 1990 |
Prevention of reocclusion by MCI-9038, a thrombin inhibitor, following t-PA-induced thrombolysis in a canine model of femoral arterial thrombosis.
Topics: Animals; Arginine; Arterial Occlusive Diseases; Disease Models, Animal; Dogs; Femoral Artery; Hemodynamics; Male; Pipecolic Acids; Recurrence; Regional Blood Flow; Sulfonamides; Thrombin; Thrombin Time; Thrombolytic Therapy; Thrombosis; Tissue Plasminogen Activator | 1990 |